Last reviewed · How we verify
salbutamol sulfate and ipratropium bromide — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
salbutamol sulfate and ipratropium bromide (salbutamol sulfate and ipratropium bromide) — Universidade Federal do Rio Grande do Norte.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| salbutamol sulfate and ipratropium bromide TARGET | salbutamol sulfate and ipratropium bromide | Universidade Federal do Rio Grande do Norte | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- salbutamol sulfate and ipratropium bromide CI watch — RSS
- salbutamol sulfate and ipratropium bromide CI watch — Atom
- salbutamol sulfate and ipratropium bromide CI watch — JSON
- salbutamol sulfate and ipratropium bromide alone — RSS
Cite this brief
Drug Landscape (2026). salbutamol sulfate and ipratropium bromide — Competitive Intelligence Brief. https://druglandscape.com/ci/salbutamol-sulfate-and-ipratropium-bromide. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab